Med Oncol News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Med oncol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Med Oncol Today - Breaking & Trending Today

Cardiff Oncology Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update

Phase 1b/2 trial in lead KRAS-mutated metastatic colorectal cancer (mCRC) program continues to show our lead candidate onvansertib demonstrates an objective. ....

Acta Oncologica , Bolus Fluorouracil , James Levine , Randolph Hecht , Kiki Patel , Williamf Novotny , Fairoozf Kabbinavar , Van Cutsem , Brent Perrou , Richa Kumari , Tod Smeal , Charles Monahan , Michael Mccleod , Fairooz Kabbinavar , Joseph Schulz , Johnt Hamm , Mark Erlander , Betty Nelson , Taral Patel , Exchange Commission , Cardiff Oncology Inc , Taft Communications , Gilmartin Group , Dana Farber Cancer Institute Phase , Cardiff Oncology , Dana Farber Cancer Institute ,

Cardiff Oncology Reports Third Quarter 2022 Results and Provides Business Updates

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a. ....

Acta Oncologica , Mark Erlander , Joyce Allaire , Van Cutsem , James Levine , Cardiff Oncology Inc , Pdac Program , Crc Program , University Of Pittsburgh Medical Center , Cardiff Oncology Expanded Access Program , Prnewswire Cardiff Oncology Inc , Exchange Commission , European Society For Medical Oncology , Dana Farber Cancer Institute , European Society , Medical Oncology , Cardiff Oncology , Expanded Access Program , Pancreatic Ductal Adenocarcinoma , Pittsburgh Medical Center , Months Ended September , Lancet Oncol , Correspondence Lancet , Med Oncol , Spring Harb Perspect Med , Looking Statements ,

Cardiff Oncology Reports Third Quarter 2022 Results and Provides Business Updates

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a. ....

Acta Oncologica , Mark Erlander , Joyce Allaire , Van Cutsem , James Levine , Cardiff Oncology Inc , Pdac Program , Crc Program , University Of Pittsburgh Medical Center , Cardiff Oncology Expanded Access Program , Prnewswire Cardiff Oncology Inc , Exchange Commission , European Society For Medical Oncology , Dana Farber Cancer Institute , European Society , Medical Oncology , Cardiff Oncology , Expanded Access Program , Pancreatic Ductal Adenocarcinoma , Pittsburgh Medical Center , Months Ended September , Lancet Oncol , Correspondence Lancet , Med Oncol , Spring Harb Perspect Med , Looking Statements ,

Cardiff Oncology Announces Plans for a Randomized Trial in Metastatic Colorectal Cancer (mCRC), Durability of Responses in Ongoing Phase 1b/2 Trial in mCRC and Additional Business Updates

Next trial in RAS-mutated mCRC (ONSEMBLE) is a randomized Phase 2 trial to demonstrate onvansertib s contribution to SoC and position for a possible. ....

Acta Oncologica , Mark Erlander , Amy Jobe , Joyce Allaire , Van Cutsem , James Levine , Cardiff Oncology Inc , Crc Program , University Of Pittsburgh Medical Center , Prnewswire Cardiff Oncology Inc , Exchange Commission , Lifesci Communications , Prostate Cancer Program , European Society For Medical Oncology , Dana Farber Cancer Institute , Cardiff Oncology , European Society , Medical Oncology , Triple Negative Breast Cancer , Small Cell Lung Cancer , Pittsburgh Medical Center , Conference Call , Lancet Oncol , Correspondence Lancet , Med Oncol , Spring Harb Perspect Med ,